MedPath

High-risk Influenza Vaccine Alert

Not Applicable
Completed
Conditions
Influenza
Interventions
Behavioral: Alert
Behavioral: Salient alert features
Behavioral: High-risk Text
Behavioral: Risk factors
Registration Number
NCT05492786
Lead Sponsor
Geisinger Clinic
Brief Summary

The purpose of this study is to assess, prospectively, the effect on flu vaccination rates of salient alerts in the electronic health record that indicate a patient's high risk for flu and its complications. The investigators hypothesize that the salient alerts will lead to increased flu vaccination compared with a standard flu alert.

Detailed Description

The CDC (Centers for Disease Control) recommends a flu vaccination to everyone aged 6+ months, with rare exception; almost anyone can benefit from the vaccine, which can reduce illnesses, missed work, hospitalizations, and death. One barrier to vaccination is a lack of "cues to action," and, in particular, the lack of direct recommendation from medical personnel; this barrier is arguably the most effectively overcome by a simple nudge of clinicians, compared with barriers such as negative attitudes toward vaccination, low perceived utility of vaccination, and less experience with having received the vaccine.

Geisinger partnered with Medial EarlySign (Medial) to develop a machine learning (ML) algorithm to help identify people at risk for serious flu-associated complications based on existing electronic health record data. Eligible at-risk patients will be randomized to an active control group (clinician will be shown a standard flu alert) or one of two experimental groups (clinician will be shown an alert indicating patient's high risk, with or without describing the patient's factors contributing to that risk).

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
80452
Inclusion Criteria
  • Age 18+
  • Have been determined to be in the top 20% of risk through Medial's ML algorithm
  • Attend an appointment where the flu alert fires (Geisinger sets when flu alerts start and end--between ~9/1/2022 and ~4/30/2023, as well as the trigger conditions for the alert, which includes valid departments and visits and excludes contraindications like Guillain-Barre syndrome)

Clinician Inclusion Criteria:

  • Any Geisinger clinician who sees patient-participants in our study for an appointment where their flu shot alert fires
Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
High-risk AlertHigh-risk TextFlu alert that indicates patient is at high risk for flu and its complications
High-risk Alert with Risk FactorsAlertFlu alert that indicates patient is at high risk for flu and its complications and presents the factors contributing to this high risk
High-risk Alert with Risk FactorsHigh-risk TextFlu alert that indicates patient is at high risk for flu and its complications and presents the factors contributing to this high risk
Standard AlertAlertStandard flu alert
High-risk Alert with Risk FactorsSalient alert featuresFlu alert that indicates patient is at high risk for flu and its complications and presents the factors contributing to this high risk
High-risk AlertAlertFlu alert that indicates patient is at high risk for flu and its complications
High-risk AlertSalient alert featuresFlu alert that indicates patient is at high risk for flu and its complications
High-risk Alert with Risk FactorsRisk factorsFlu alert that indicates patient is at high risk for flu and its complications and presents the factors contributing to this high risk
Primary Outcome Measures
NameTimeMethod
Flu VaccinationAt the 1 day visit

Patient received a flu vaccine (yes/no)

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Geisinger Clinic

🇺🇸

Danville, Pennsylvania, United States

© Copyright 2025. All Rights Reserved by MedPath